114 related articles for article (PubMed ID: 38554328)
1. Prognostic value of radiomic features in patients with esophageal cancer treated with chemoradiotherapy.
Jinnouchi H; Yamashita H; Nozawa Y; Nakamoto T; Sawayanagi S; Katano A
J Cancer Res Ther; 2024 Jan; 20(1):243-248. PubMed ID: 38554328
[TBL] [Abstract][Full Text] [Related]
2. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an [
Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
[TBL] [Abstract][Full Text] [Related]
6. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
[TBL] [Abstract][Full Text] [Related]
9. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
10. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
[TBL] [Abstract][Full Text] [Related]
11. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Radiomics Analysis of Skeletal Muscle After Radical Irradiation of Esophageal Cancer.
Iwashita K; Kubota H; Nishioka R; Emoto Y; Kawahara D; Ishihara T; Miyawaki D; Nishibuchi I; Nagata Y; Sasaki R
Anticancer Res; 2023 Apr; 43(4):1749-1760. PubMed ID: 36974798
[TBL] [Abstract][Full Text] [Related]
14. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.
Amrane K; Thuillier P; Bourhis D; Le Meur C; Quere C; Leclere JC; Ferec M; Jestin-Le Tallec V; Doucet L; Alemany P; Salaun PY; Metges JP; Schick U; Abgral R
Sci Rep; 2023 Apr; 13(1):5789. PubMed ID: 37031233
[TBL] [Abstract][Full Text] [Related]
16. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
17. Prediction of distant metastasis in esophageal cancer using a radiomics-clinical model.
Zhu C; Mu F; Wang S; Qiu Q; Wang S; Wang L
Eur J Med Res; 2022 Dec; 27(1):272. PubMed ID: 36463269
[TBL] [Abstract][Full Text] [Related]
18. The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.
Yang Z; Gong J; Li J; Sun H; Pan Y; Zhao L
Int J Surg; 2023 Aug; 109(8):2451-2466. PubMed ID: 37463039
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a
Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
[TBL] [Abstract][Full Text] [Related]
20. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]